Jun 2021 $39 M Private placement after listing $10 to $50 million 12
Kempharm Inc.: Private sale, Jun 2021 × Investors in this round 12 investors had bought by the notice of Jun 22, 2021: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $39 M of $39 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,345,912
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice R. LaDuane Clifton · Executive Officer Sven LaDuane Guenther · Executive Officer Timothy J. Sangiovanni · Executive Officer Travis C. Mickle · Executive Officer, Director, Promoter David S. Tierney · Director Joseph B. Saluri · Director Matthew R. Plooster · Director Richard W. Pascoe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Roth Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in CA, CT, MA, NJ, NY Signed by R. LaDuane Clifton, CFO, Treas & Sec. Source: SEC Form D, newest notice filed Jun 22, 2021. Read the notice at the SEC .
options SEC Jan 2021 $44 M Private placement after listing $10 to $50 million 15
Kempharm Inc.: Private sale, Jan 2021 × Investors in this round 15 investors had bought by the notice of Feb 4, 2021: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $44 M of $44 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,641,523
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice R. LaDuane Clifton · Executive Officer Sven LaDuane Guenther · Executive Officer Timothy J. Sangiovanni · Executive Officer Travis C. Mickle · Executive Officer, Director, Promoter David S. Tierney · Director Joseph B. Saluri · Director Matthew R. Plooster · Director Richard W. Pascoe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Roth Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in CA, CT, MA, NJ, NV, NY Signed by R. LaDuane Clifton, CFO, Treas & Sec. Source: SEC Form D, newest notice filed Feb 4, 2021. Read the notice at the SEC .
options SEC Jan 2021 $31 M Private placement after listing $10 to $50 million 4
Kempharm Inc.: Private sale, Jan 2021 × Investors in this round 4 investors had bought by the notice of Jan 13, 2021: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $31 M of $31 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $2,000,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice R. LaDuane Clifton · Executive Officer Sven LaDuane Guenther · Executive Officer Timothy J. Sangiovanni · Executive Officer Travis C. Mickle · Executive Officer, Director, Promoter David S. Tierney · Director Joseph B. Saluri · Director Matthew R. Plooster · Director Richard W. Pascoe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cowen & Company, LLC (CRD 7616) · New York, New York Sold in IL, NY Remarks in the notice On the amounts: “Securities issued in the offering include shares of Series B-2 Preferred Stock and warrants to purchase common stock. Securities were issued in exchange for a portion of the principal amount of outstanding convertible promissory notes.”Signed by R. LaDuane Clifton, CFO, Treas & Sec. Source: SEC Form D, newest notice filed Jan 13, 2021. Read the notice at the SEC .
equity, options SEC Oct 2018 $1 M Private placement after listing Under $2 million 1
Kempharm Inc.: Private sale, Oct 2018 × Investors in this round 1 investor had bought by the notice of Nov 2, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gordon K. Johnson · Executive Officer R. LaDuane Clifton · Executive Officer Sven K. Guenther · Executive Officer Timothy J. Sangiovanni · Executive Officer Travis C. Mickle · Executive Officer, Director, Promoter Danny L. Thompson · Director David S. Tierney · Director Joseph B. Saluri · Director Matthew R. Plooster · Director Richard W. Pascoe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by R. LaDuane Clifton, CFO, Treas & Sec. Source: SEC Form D, newest notice filed Nov 2, 2018. Read the notice at the SEC .
options SEC Feb 2015 $4 M No. 3 $2 to $10 million 1
Kempharm Inc.: Raise no. 3, Feb 2015 × Investors in this round 1 investor had bought by the notice of Mar 4, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christal M.M. Mickle · Executive Officer, Director Gordon K. Johnson · Executive Officer Sven Guenther · Executive Officer, Director Tracy M. Woody · Executive Officer Travis C. Mickle · Executive Officer, Director, Promoter Danny L. Thompson · Director David S. Tierney · Director Jonathan S. Leff · Director Joseph B. Saluri · Director Matthew R. Plooster · Director Richard W. Pascoe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gordon K. Johnson, Chief Operating Officer and Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 4, 2015. Read the notice at the SEC .
equity SEC Jul 2010 $7 M No. 2 $2 to $10 million 216
Kempharm Inc.: Raise no. 2, Jul 2010 × Investors in this round 216 investors had bought by the notice of Jun 30, 2011: 215 accredited, 1 not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $7 M of $25 M offered; $18 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $2,125,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Iowa People named in the notice Christal M.M. Mickle · Executive Officer, Director Kathleen H. Holt · Executive Officer Sven J. Guenther · Executive Officer Todd J. Johnson · Executive Officer, Director Travis C. Mickle · Executive Officer, Director, Promoter Adam J. Claypool · Director Danny J. Thompson · Director Matt J. Plooster · Director Todd J. Doorenbos · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Adam Stone Claypool (CRD 2572486) · broker-dealer DeWaay Financial Network, LLC (CRD 30767) · Clive, Iowa Sold in all US states Remarks in the notice On fees: “Reduced cash comm. is paid for shares sold to affiliates. Plcmt Agt receives warrant to purchase shares of Class A Common Stock equal to 15.0% of the Common Stock shares issuable upon conversion into Common Stock of Shares subscribed in this offering.”Signed by Travis Mickle, President. Source: SEC Form D, newest notice filed Jun 30, 2011. Read the notice at the SEC .
equity SEC Apr 2009 $3 M No. 1 $2 to $10 million 134
Kempharm Inc.: Raise no. 1, Apr 2009 × Investors in this round 134 investors had bought by the notice of Aug 27, 2009: 134 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Kempharm Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $170,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Iowa People named in the notice Christal Mickle · Executive Officer, Director Robert Karr · Executive Officer, Director Travis Mickle · Executive Officer, Director, Promoter Adam Claypool · Director Dan Thompson · Director Robert Beardsley · Director Todd Johnson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Adam Stone Claypool (CRD 2572486) · broker-dealer DeWaay Financial Network, LLC (CRD 30767) · Clive, Ia Sold in all US states Remarks in the notice On fees: “The maximum sales commission which may be payable is $327,794, together with a warrant for class A common stock, the value of which cannot be determined at this time.”Signed by Travis Mickle, President. Source: SEC Form D, newest notice filed Aug 27, 2009. Read the notice at the SEC .
equity SEC